Astrocytes regulate signal speeds of neurons: Study
The transmission speed of neurons fluctuates in the brain to achieve an optimal flow of information required for day-to-day activities, according to a National Institutes of Health study. The results, appearing in PNAS, suggest that brain cells called astrocytes alter the transmission speed of neurons by changing the thickness of myelin, an insulation material, and the width of gaps in myelin called nodes of Ranvier, which amplify signals.
The brain is composed of neurons, which have extensions called axons that can stretch for long distances. Axons are wrapped by layers of myelin, which serve as insulation to increase the speed of signals relayed by neurons. Gaps between segments of myelin are called nodes of Ranvier, and the number and width of these gaps can also regulate transmission speed.
The researchers focused their attention on perinodal astrocytes, which frequently touch nodes of Ranvier throughout the brain. In experiments using mice and rats, the researchers found that these astrocytes regulate adhesion molecules that connect myelin to axons. When these molecules are cut by the enzyme thrombin, myelin detaches from the axon, layer by layer.
The researchers blocked the ability of perinodal astrocytes to regulate thrombin and observed thinner myelin sheaths and wider nodes of Ranvier. In turn, these changes reduced the signal speeds of neurons by approximately 15 percent, which was enough to impair reflexes of mice in a vision-based test.
The findings suggest that astrocytes, by regulating signal speeds, play an important role in how the brain processes information. Furthermore, the researchers propose that blocking thrombin may help stabilize myelin. Thrombin inhibitors are already approved by the U.S. Food and Drug Administration for other uses, and the study team is currently testing their idea in a mouse model of multiple sclerosis.
Funding for the work was provided by NICHD and other NIH components, including the Center for Information Technology, the National Institute of Neurological Disorders and Stroke, and the National Cancer Institute. Additional support was provided by the Department of Defense through the Henry M. Jackson Foundation for the Advancement of Military Medicine.